Scarica l'app Stockscreener
1.31
2.24%
-0.03
Dopo l'orario di chiusura:
1.31
Precedente Chiudi:
$1.34
Aprire:
$1.36
Volume 24 ore:
2.19M
Relative Volume:
4.24
Capitalizzazione di mercato:
$108.30M
Reddito:
-
Utile/perdita netta:
$-21.65M
Rapporto P/E:
-3.9446
EPS:
-0.3321
Flusso di cassa netto:
$-15.84M
1 W Prestazione:
+32.87%
1M Prestazione:
+1.55%
6M Prestazione:
+7.38%
1 anno Prestazione:
-35.78%
Intervallo 1D:
$1.30
$1.4199
Intervallo di 1 settimana:
$0.9758
$1.4199
Portata 52W:
$0.7709
$2.63
Cardiol Therapeutics Inc Stock (CRDL) Company Profile
Confronta CRDL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CRDL
Cardiol Therapeutics Inc
|
1.31 | 110.75M | 0 | -21.65M | -15.84M | -0.3321 |
|
ZTS
Zoetis Inc
|
154.11 | 67.83B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.00 | 46.74B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.65 | 43.52B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.86 | 20.12B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
313.13 | 14.11B | 2.99B | 1.21B | 1.13B | 25.06 |
Cardiol Therapeutics Inc Stock (CRDL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-02 | Iniziato | H.C. Wainwright | Buy |
| 2025-01-28 | Iniziato | Rodman & Renshaw | Buy |
| 2024-06-26 | Iniziato | ROTH MKM | Buy |
| 2024-04-22 | Iniziato | H.C. Wainwright | Buy |
Cardiol Therapeutics Inc Borsa (CRDL) Ultime notizie
Cardiol Therapeutics Reports Q2 2025 Financial Results Amid Rising Losses - MSN
Cardiol Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
The Significance of Moving Averages in Cardiol Therapeutics Inc Inc. (CRDL) Price Performance - investchronicle.com
Healthcare Analysts Bullish on SI-Bone, Delcath Systems, and Cardiol Therapeutics - AInvest
Chart based analysis of Cardiol Therapeutics Inc. trendsJuly 2025 Update & Free Real-Time Market Sentiment Alerts - Newser
What technical models suggest about Cardiol Therapeutics Inc.’s comebackPortfolio Risk Summary & Entry and Exit Point Strategies - Newser
How to integrate Cardiol Therapeutics Inc. into portfolio analysis toolsJuly 2025 Chart Watch & Precise Entry and Exit Recommendations - Newser
Relief Rally in Cardiol Therapeutics Inc. Stock — Can It Hold [Insider Selling]Low Drawdown Trading Strategies - 선데이타임즈
Will Cardiol Therapeutics Inc. stock go up soon [2025 Trading Volume Trends]Free Community Trade Idea Sharing Platform - Newser
Why is Cardiol Therapeutics Inc. stock going downBig Return Within 7 Days - thegnnews.com
Analyzing Cardiol Therapeutics Inc. with multi timeframe chartsAI-Based Stock Behavior Forecast Engine - Newser
Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH) - TradingView
Analyzing drawdowns of Cardiol Therapeutics Inc. with statistical toolsWeekly Growth Portfolio Performance Summary - Newser
Pharmaceutical Company Discovers Breakthrough Heart Treatment in Canada - streetwisereports.com
Canadian Pharmaceutical Company Discovers Breakthrough Cardiovascular Treatment - streetwisereports.com
Biotech Announces Topline Results From Cardiovascular Drug Trial - streetwisereports.com
Cardiol Therapeutics to Participate in Fireside Chat at Canaccor - GuruFocus
Cardiol Therapeutics to Present at Canaccord Genuity Conference - TipRanks
Fluor Acknowledges Court Decision on Santos’ Gladstone LNG Project - The Globe and Mail
Cardiol Therapeutics to Participate in Fireside Chat at Canaccord Genuity's 45th Annual Growth Conference - Newsfile
Cardiol Therapeutics Reveals Latest Heart Disease Treatment Progress at Major Growth Conference - Stock Titan
Moving Average Trends for Cardiol Therapeutics Inc. Stock: What They IndicateEntry Confirmation Based on Volatility Analysis - Newser
Canadian Pharma Finds Promising Cardiovascular Breakthrough - streetwisereports.com
Watch for Trend Continuation in Cardiol Therapeutics Inc. Next WeekPortfolio Diversification Stock Ideas From Experts - beatles.ru
Cardiol Therapeutics (CRDL) Expected to Announce Earnings on Monday - Defense World
(CRDL) Risk-Controlled Trading Report (CRDL:CA) - news.stocktradersdaily.com
Cardiol Therapeutics CRDL 2025Q2 Earnings Preview Upside Potential on Strategic Partnerships - AInvest
Cardiol Therapeutics Inc expected to post a loss of 12 cents a shareEarnings Preview - TradingView
Is Cardiol Therapeutics a buy? - Cantech Letter
Cardiol Therapeutics’ stock down 20% on Phase II CardiolRx failure - Yahoo Finance
Cardiol Therapeutics Announces US Listing - thedeepdive.ca
Cardiol Therapeutics shares rise 7.48% premarket after positive ARCHER trial results for CardiolRx™. - AInvest
Cardiol falls after mid-stage data for heart disease treatment - MSN
Roth bullish on Cardiol, says trial results enough to attract larger partner - TipRanks
Quantum Biopharma Ltd. shares rise 1.19% after-hours following Cardiol Therapeutics' positive ARCHER trial results. - AInvest
Cardiol data readout positive and not priced in, says H.C. Wainwright - TipRanks
Cardiol Therapeutics’ Cannabidiol Formulation Reduced Inflammation—Phase II Topline Data Ignites the Race to Treat Acute Myocarditis - InvestorNews
Cardiol ARCHER study not statistically significant, says Canaccord - TipRanks
Cardiol Therapeutics Announces Topline Results from the Phase II ARCHER Trial of CardiolRx(TM) in Acute Myocarditis - Barchart.com
Cardiol Therapeutics Reports Promising Phase II Trial Results for CardiolRx™ in Acute Myocarditis - TipRanks
Cardiol falls after mid-stage data for heart disease drug - Seeking Alpha
Cardiol Therapeutics Announces Topline Results from the Phase II - GuruFocus
(CRDL) Trading Report (CRDL:CA) - news.stocktradersdaily.com
Cardiol Therapeutics Inc. Recovery Gathers Momentum on Chart SignalsWatchlist for Smart Swing Trading Updated - beatles.ru
Is Cardiol Therapeutics Inc. in Accumulation Phase NowOptimized Watchlist With Daily Adjustments Launched - metal.it
What is the dividend policy of Cardiol Therapeutics Inc. stockGet daily updates on promising stocks - Jammu Links News
Published on: 2025-08-04 07:27:14 - metal.it
What institutional investors are buying Cardiol Therapeutics Inc. stockRobust investment performance - Jammu Links News
How does Cardiol Therapeutics Inc. compare to its industry peersCapitalize on stocks with high profit margins - Jammu Links News
(CRDL) Comprehensive Trading Strategy Report (CRDL:CA) - news.stocktradersdaily.com
What makes Cardiol Therapeutics Inc. stock price move sharplyFree Trend-Following Techniques - Jammu Links News
Cardiol Therapeutics Inc Azioni (CRDL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.80%
0.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):